全球血球比容檢測設備市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計到 2034 年，血球容積比檢測設備市場規模將從 2025 年的 61.8 億美元成長至 87.3 億美元，2026 年至 2034 年的複合年成長率為 3.91%。

全球血球容積比檢測市場持續穩定成長，主要受全球貧血和紅血球增多症等血液疾病盛行率不斷上升的所推動。血球容積比檢測在常規診斷、急診醫學和慢性病管理中發揮著至關重要的作用。醫療保健成本的不斷上漲以及人們對疾病早期檢測意識的提高，顯著促進了醫院、診所和診斷檢查室的市場擴張。

關鍵成長要素包括就地檢驗設備的科技進步，這些設備能夠提供快速且準確的檢測結果。偏遠地區和資源匱乏地區對攜帶式、易用型診斷工具的需求不斷成長，進一步推動了市場發展。捐血計畫的擴展和定期健康檢查的實施也增加了全球對血球比容檢測設備的需求。

未來，微流體技術和自動化診斷系統的創新可望惠及市場。與數位健康平台和數據分析工具的整合將提高診斷效率。新興經濟體可望迎來顯著的成長機遇，這得益於各國政府旨在擴大醫療基礎設施和提升診斷能力的政策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球血球容積比檢測設備市場：依產品分類

• 市場分析、洞察與預測
• 血液分析儀
• 血球比容計
• 其他

第5章 全球血球容積比檢測設備市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院及門診手術中心
• 診所
• 診斷和病理檢查室
• 其他

第6章 全球血球容積比檢測設備市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Nihon Kohden Corporation
  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • Siemens Healthineers（Siemens AG）
  • EKF Diagnostics Holdings Plc
  • Sysmex Corporation
  • Nova Biomedical
  • Abbott
  • HORIBA Ltd
  • Boule Diagnostics

The Hematocrit Test Devices Market size is expected to reach USD 8.73 Billion in 2034 from USD 6.18 Billion (2025) growing at a CAGR of 3.91% during 2026-2034.

The Global Hematocrit Test Devices Market is growing steadily as blood-related disorders such as anemia and polycythemia become more prevalent worldwide. Hematocrit testing plays a crucial role in routine diagnostics, emergency care, and chronic disease management. Rising healthcare expenditure and increasing awareness about early disease detection are contributing significantly to market expansion across hospitals, clinics, and diagnostic laboratories.

Key growth drivers include technological advancements in point-of-care testing devices that offer rapid and accurate results. The growing demand for portable and user-friendly diagnostic tools in remote and resource-limited settings further supports market development. Expansion of blood donation programs and routine health screenings also increases the need for hematocrit testing equipment globally.

In the future, the market is expected to benefit from innovation in microfluidics and automated diagnostic systems. Integration with digital health platforms and data analytics tools will enhance diagnostic efficiency. Emerging economies are projected to offer substantial growth opportunities due to expanding healthcare infrastructure and government initiatives aimed at improving diagnostic capabilities.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Blood Analyzers
• Hematocrit Test Meters
• Others

By End User

• Hospitals & Ambulatory Surgical Centers
• Clinics
• Diagnostic & Pathology Labs
• Others

COMPANIES PROFILED

• Nihon Kohden Corporation, F HoffmannLa Roche Ltd, Danaher Corporation, Siemens Healthineers Siemens AG, EKF Diagnostics Holdings plc, Sysmex Corporation, Nova Biomedical, Abbott, HORIBA Ltd, Boule Diagnostics
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEMATOCRIT TEST DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Blood Analyzers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Hematocrit Test Meters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEMATOCRIT TEST DEVICES MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Hospitals & Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Diagnostic & Pathology Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEMATOCRIT TEST DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By End User
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By End User
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By End User
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By End User
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By End User
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL HEMATOCRIT TEST DEVICES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Nihon Kohden Corporation
  • 8.2.2 F. Hoffmann-La Roche Ltd
  • 8.2.3 Danaher Corporation
  • 8.2.4 Siemens Healthineers (Siemens AG)
  • 8.2.5 EKF Diagnostics Holdings Plc
  • 8.2.6 Sysmex Corporation
  • 8.2.7 Nova Biomedical
  • 8.2.8 Abbott
  • 8.2.9 HORIBA Ltd
  • 8.2.10 Boule Diagnostics